Leucine's $7M series A funding to remedy 'not fit for purpose' compliance protocol processes 16-Oct-2023 By Liza Laws AI start-up, Leucine, claims ‘not fit for purpose’ compliance protocol processes are hindering the ability to deliver life-saving drugs faster.